Pete good post there are a number of possibilities when you drugs that are potential blockbusters that starved BP want. I think now they are locked into finalizing the binding agreement. Of course the P results could bring up new terms, new partnerships or outright acquisition. The only thing that could mess this up at this point is Leo. P was messed upped for a number of reasons. I blame Leo for not signing a B deal a year ago. I bet another 10,000 shares on a successful outcome. May up it more next week. The 10k does warrant a PR. Since were finalizing a binding agreement, I doubt we’ll get one, which may risk it. At this point the deal is for B-OM and B-IBD. Let’s think about B-OM, showing preventative efficacy was quite remarkable. IBD pics definitive. This should be soaring, but the way the 10K read not surprising. I’m thinking calmer heads prevail next week, and folks will realize IPIX is final a binding agreement and this can soar with the odds way in IPIXs favor. B is very valuable, and has demonstrated as such.